Our Services

Our services in cells and gene therapy encompass advanced treatments and technologies aimed at revolutionizing healthcare. We specialize in the development and manufacturing of various cell-based therapies, including Mesenchymal Stem Cells (MSCs), Hematopoietic Stem Cells (HSCs), and engineered T-cells such as CAR-T and CAR-NK cells. These therapies are designed to target and treat complex diseases, including cancers, autoimmune disorders, and genetic conditions. Additionally, we offer gene editing services using cutting-edge techniques like CRISPR/Cas9 to engineer stem cells with specific therapeutic properties. Our expertise extends to tissue engineering and the creation of organoids for regenerative medicine and disease modeling. By providing customized solutions, regulatory support, and collaborative research opportunities, we aim to advance the field of cell and gene therapy, bringing innovative and personalized treatments to patients.

Another key area of CellsXpert’s expertise is the manufacturing of Hematopoietic Stem Cells (HSCs) for bone marrow transplantation. These high-quality HSCs are crucial for treating blood disorders such as leukemia, lymphoma, and aplastic anemia. CellsXpert ensures the long-term storage and viability of HSCs through advanced cryopreservation techniques, making them available for future transplantation needs.

CellsXpert also develops and manufactures Chimeric Antigen Receptor T cells (CAR-T cells) and Chimeric Antigen Receptor Natural Killer cells (CAR-NK cells). CAR-T cells are genetically engineered to target and destroy cancer cells and have shown significant success in treating certain types of blood cancers, such as B-cell acute lymphoblastic leukemia and diffuse large B-cell lymphoma. CAR-NK cells combine the targeting ability of CAR technology with the innate immune properties of NK cells, offering potential treatments for both blood cancers and solid tumors.

In addition to these therapies, CellsXpert utilizes gene editing technologies like CRISPR-Cas9 to engineer stem cells. These engineered stem cells are used to correct genetic defects, enhance therapeutic efficacy, and create disease models for research. This capability is pivotal for developing personalized medicine and advanced research tools.

CellsXpert also specializes in the production of induced pluripotent stem cells (iPSCs), which are reprogrammed adult cells that can differentiate into any cell type. These iPSCs are invaluable for disease modeling, drug discovery, and the development of personalized regenerative therapies. In the field of tissue engineering, CellsXpert manufactures biocompatible scaffolds that support the growth and differentiation of stem cells into functional tissues. They also create organoids, which are miniature, simplified versions of organs, used for disease modeling, drug testing, and regenerative medicine.

Furthermore, CellsXpert offers FDA-approved services including autologous cell therapies, where a patient’s own cells are modified and expanded ex vivo before being reintroduced into the body, and allogeneic cell therapies, which are off-the-shelf treatments derived from donor cells standardized for widespread clinical use. They also develop and manufacture cell-based vaccines for infectious diseases and cancer immunotherapy.

Overall, CellsXpert’s comprehensive range of services and advanced technologies position them at the forefront of cell therapy and regenerative medicine, driving innovative treatments for a variety of diseases and medical conditions.